PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026Neuropathology and Applied Neurobiology0 citationsOpen Access

Enhancing the Performance of a Blood‐Based Diagnostic Screening Tool for Dysferlinopathy: Optimising an Immunoassay Across Continents

View Full Paper
GDG. D'EsteIRCCS San Camillo HospitalDCDan CoxMuscular Dystrophy UKLMLorenza MaistrelloIRCCS San Camillo Hospital

Key Points

  • The blood-based dysferlin assay shows promise as a reliable screening tool, benefiting from proper sample handling.
  • Diagnostic accuracy depends heavily on optimal storage conditions and training in collection techniques.

Structured PICO

I
Intervention
PBF-based dysferlin assay
O
Outcome
Diagnostic accuracy and reliability

The PBF-based dysferlin assay is a rapid and cost-effective screening tool for dysferlinopathy that requires strict adherence to sample collection and storage protocols for reliability.

Abstract

The PBF-based dysferlin assay is a rapid, cost-effective and minimally invasive screening tool, well-suited for use in resource-limited settings. It provides a viable approach for initial screening and variant assessment. As the assay's reliability is influenced by sample quality and storage conditions, proper training in collection techniques and strict adherence to storage protocols are essential for ensuring diagnostic accuracy and enabling broader clinical application.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

D'Este et al. (2026) studied this question.

synapsesocial.com/papers/69a75be0c6e9836116a23fcfhttps://doi.org/10.1111/nan.70060
Ask AI
Helpful
Bookmark
Share
View Full Paper